Therapeutic systems: characteristics, differential signs, assortment analysis

DOI: https://doi.org/10.29296/25419218-2022-05-04
Issue: 
5
Year: 
2022

E.T. Zhilyakova, N.V. Avtina, A.V. Bondarev
Belgorod State National Research University, 85 Victory str., Belgorod, 308015, Russian Federation

Introduction. Pharmaceutical development of medicines in the form of therapeutic systems with long-lasting effects is a priority area of pharmaceutical technology. Currently, the share of medicines registered in the State Register of Medicines as therapeutic systems is insignificant. In addition, some signs and characteristics of registered therapeutic systems (in particular, transdermal) have almost identical signs of the following dosage forms: transdermal patches, medical patches, films. In this connection, the analysis and systematization of regulatory documentation of dosage forms having similar signs and characteristics is timely and relevant. Objective: to determine the differential signs of therapeutic systems, as a dosage form, based on the analysis of regulatory documentation and scientific and technical literature. Material and methods. Regulatory documentation was used as research materials: general pharmacopoeia articles of the State Pharmacopoeia of the XIV ed. on medicinal forms "Therapeutic systems", "Transdermal Plasters", "Medical Plasters", "Films"; State Register of Medicines; electronic resources eLibrary, CyberLeninka. Research methods – content analysis and system analysis of regulatory documentation, the State Register of Medicines, scientific and technical publications. Results. The analysis of the domestic market of registered medicines in the form of therapeutic systems is carried out; the main characteristics of the dosage form "Therapeutic systems" are determined, allowing to differentiate it from similar dosage forms; the classification of the dosage form "Therapeutic Systems" is proposed, which allows to fully characterize the dosage form. Conclusion. There are eight trade names of medicines on the pharmaceutical market of the Russian Federation, the form of release of which are therapeutic systems: transdermal, intrauterine, vaginal. The main characteristics of the dosage form "Therapeutic systems" have been determined, which allow differentiating it from similar dosage forms that provide a long-lasting systemic or local pharmacological effect. The classification of the dosage form "Therapeutic systems" is proposed, which allows it to fully characterize.

Keywords: 
transdermal/vaginal/intrauterine therapeutic systems
transdermal patches.

References: 
  1. The State Pharmacopoeia of The Russian Federation, XIV ed., volume II, General monograph. 1.4.1.0038.18 «Therapeutic systems». [Electronic edition]. Access mode: https://docs.rucml.ru/feml/pharma/v14/vol2/. [Accessed 25 March, 2022] (in Russian).
  2. State Register of Medicines [Electronic edition]. Access mode: http://grls.rosminzdrav.ru. [Accessed 30 March, 2022] (in Russian).
  3. Petrukhina D.A., Pletneva I.V., Pokrovskaya Yu.S. Research on the creation of an application system for the treatment of wound processes. Medical and pharmaceutical journal Pulse. 2021; 23 (2): 74–9. DOI: 10.26787/nydha-2686-6838-2021-23-2-74-79 (in Russian).
  4. Kuznetsova E.G., Kuryleva O.M., Salomatina L.A., Sevastyanov V.I. Application of synthetic and biological test systems in the development of transdermal therapeutic systems. Promising materials. 2020; 8: 49058. DOI: 10.30791/1028-978X-2020-8-49-58 (in Russian).
  5. Bakhrushina E.O., Anurova M.N., Demina N.B., etc. Ophthalmic drug delivery systems (review). Development and registration of medicines. 2021; 10 (1): 57–66. DOI: 10.33380/2305-2066-2021-10-1-57-66 (in Russian).
  6. Uzdenova I.A., Musaeva K.I. Application of transdermal therapeutic systems in endocrine diseases. An ambulance doctor.2020; 6: 24–32. DOI: 10.33920/med-02-2006-01 (in Russian).
  7. Gildeeva G.N. Yezhova E.A., Zakalyukina E.V., Ivanova A.A. Transdermal therapeutic systems as a convenient alternative to traditional medicinal forms. Problems of social hygiene, health care and the history of medicine. 2019; 27 (6): 997–1002. DOI: 10.32687/0869-866X-2019-27-6-997-1002 (in Russian).
  8. Sokolova E.A., Mokhova E.K., Gordienko M.G. New transdermal therapeutic systems based on polyvinyl alcohol and chitosan with embedded selenium nanoparticles. Advances in chemistry and chemical technology. 2021, 35 (12): 146–8 (in Russian).
  9. Sablina S.N., Elovikova T.M., Grigoriev S.S., etc. A modern view on the use of transmucoid therapeutic systems in the form of film compositions in periodontology. Problems of dentistry. 2020; 16 (3): 11–7. DOI: 10.18481/2077-7566-2020-16-3-11-17 (in Russian).
  10. Martseva D.S., Zhilyakova E.T., Ryabykh A.A., Balloul Ghadeer. Development of the composition and technology of a therapeutic system for the treatment of otitis media with perforation of the tympanic membrane. Sat. tez. dokl. II International Scientific and Practical Conference. "Harmonization of approaches to pharmaceutical development". Moscow, 2019; 185–6 (in Russian).